Related references
Note: Only part of the references are listed.ΔNp63α induces quiescence and downregulates the BRCA1 pathway in estrogen receptor-positive luminal breast cancer cell line MCF7 but not in other breast cancer cell lines
Ruhul Amin et al.
MOLECULAR ONCOLOGY (2016)
Identification of Dormancy-Associated MicroRNAs for the Design of Osteosarcoma-Targeted Dendritic Polyglycerol Nanopolyplexes.
Galia Tiram et al.
ACS NANO (2016)
The hypoxic tumor microenvironment: A driving force for breast cancer progression
Gregg L. Semenza
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2016)
Regulation of the ErbB network by the MIG6 feedback loop in physiology, tumor suppression and responses to oncogene-targeted therapeutics
Sergio Anastasi et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2016)
Generation of a monoclonal antibody recognizing the CEACAM glycan structure and inhibiting adhesion using cancer tissue-originated spheroid as an antigen
Yumi Sato et al.
SCIENTIFIC REPORTS (2016)
SMAD signaling and redox imbalance cooperate to induce prostate cancer cell dormancy
Anh Thu Bui et al.
CELL CYCLE (2015)
Mitotic quiescence, but not unique stemness, marks the phenotype of bone metastasis-initiating cells in prostate cancer
Ning Wang et al.
FASEB JOURNAL (2015)
Notch promotes recurrence of dormant tumor cells following HER2/neu-targeted therapy
Daniel L. Abravanel et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
The epigenetic/noncoding origin of tumor dormancy
Francesco Crea et al.
TRENDS IN MOLECULAR MEDICINE (2015)
NR2F1 controls tumour cell dormancy via SOX9-and RAR beta-driven quiescence programmes
Maria Soledad Sosa et al.
NATURE COMMUNICATIONS (2015)
Loss of MIG6 Accelerates Initiation and Progression of Mutant Epidermal Growth Factor Receptor-Driven Lung Adenocarcinoma
Tapan K. Maity et al.
CANCER DISCOVERY (2015)
Intact LKB1 activity is required for survival of dormant ovarian cancer spheroids
Teresa Peart et al.
ONCOTARGET (2015)
Radiation sensitivity assay with a panel of patient-derived spheroids of small cell carcinoma of the cervix
Aya Nakajima et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence
Holly E. Barker et al.
NATURE REVIEWS CANCER (2015)
The TGFβ-miR200-MIG6 Pathway Orchestrates the EMT-Associated Kinase Switch That Induces Resistance to EGFR Inhibitors
Evgeny Izumchenko et al.
CANCER RESEARCH (2014)
Dormancy of Cancer Cells with Suppression of AKT Activity Contributes to Survival in Chronic Hypoxia
Hiroko Endo et al.
PLOS ONE (2014)
Mechanisms of disseminated cancer cell dormancy: an awakening field
Maria Soledad Sosa et al.
NATURE REVIEWS CANCER (2014)
Hypoxia and the extracellular matrix: drivers of tumour metastasis
Daniele M. Gilkes et al.
NATURE REVIEWS CANCER (2014)
Spheroid Culture of Primary Lung Cancer Cells with Neuregulin 1/HER3 Pathway Activation
Hiroko Endo et al.
JOURNAL OF THORACIC ONCOLOGY (2013)
The Relative Expression of Mig6 and EGFR Is Associated with Resistance to EGFR Kinase Inhibitors
Xiaofei Chang et al.
PLOS ONE (2013)
Hypoxia induces gefitinib resistance in non-small-cell lung cancer with both mutant and wild-type epidermal growth factor receptors
Kunihiko Minakata et al.
CANCER SCIENCE (2012)
Lung cancers with acquired resistance to EGFR inhibitors occasionally harbor BRAF gene mutations but lack mutations in KRAS, NRAS, or MEK1
Kadoaki Ohashi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Cancer cells that survive radiation therapy acquire HIF-1 activity and translocate towards tumour blood vessels
Hiroshi Harada et al.
NATURE COMMUNICATIONS (2012)
HER2 Amplification: A Potential Mechanism of Acquired Resistance to EGFR Inhibition in EGFR-Mutant Lung Cancers That Lack the Second-Site EGFRT790M Mutation
Ken Takezawa et al.
CANCER DISCOVERY (2012)
Intra-tumour heterogeneity: a looking glass for cancer?
Andriy Marusyk et al.
NATURE REVIEWS CANCER (2012)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Retaining cell-cell contact enables preparation and culture of spheroids composed of pure primary cancer cells from colorectal cancer
Jumpei Kondo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Downregulation of c-MYC Protein Levels Contributes to Cancer Cell Survival under Dual Deficiency of Oxygen and Glucose
Hiroaki Okuyama et al.
CANCER RESEARCH (2010)
Crosstalk to Stromal Fibroblasts Induces Resistance of Lung Cancer to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors
Wei Wang et al.
CLINICAL CANCER RESEARCH (2009)
Hepatocyte Growth Factor Induces Gefitinib Resistance of Lung Adenocarcinoma with Epidermal Growth Factor Receptor-Activating Mutations
Seiji Yano et al.
CANCER RESEARCH (2008)
Hypoxia-mediated selective mRNA translation by an internal ribosome entry site-independent mechanism
Regina M. Young et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Hypoxia promotes the differentiated human articular chondrocyte phenotype through SOX9-dependent and -independent pathways
Jerome E. Lafont et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
A hypoxia-controlled cap-dependent to cap-independent translation switch in breast cancer
Steve Braunstein et al.
MOLECULAR CELL (2007)
Constraint and turnover in sex-biased gene expression in the genus Drosophila
Yu Zhang et al.
NATURE (2007)
Activation of insulin-like growth factor signaling induces apoptotic cell death under prolonged hypoxia by enhancing endoplasmic reticulum stress response
Hiroko Endo et al.
CANCER RESEARCH (2007)
MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling
Jeffrey A. Engelman et al.
SCIENCE (2007)
Evidence that MIG-6 is a tumor-suppressor gene
Y-W Zhang et al.
ONCOGENE (2007)
Gene 33/RALT is induced by hypoxia in cardiomyocytes, where it promotes cell death by suppressing phosphatidylinositol 3-kinase and extracellular signal-regulated kinase survival signaling
Dazhong Xu et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
Role of hypoxia-inducible factor (HIF)-1α-versus HIF-2α in the regulation of HIF target genes in response to hypoxia, insulin-like growth factor-1, or loss of von Hippel-Lindau function:: Implications for targeting the HIF pathway
Veronica A. Carroll et al.
CANCER RESEARCH (2006)
Mig6 is a negative regulator of EGF receptor-mediated skin morphogenesis and tumor formation
Ingvar Ferby et al.
NATURE MEDICINE (2006)
Ribosomal protein S6 phosphorylation: from protein synthesis to cell size
Igor Ruvinsky et al.
TRENDS IN BIOCHEMICAL SCIENCES (2006)
Acquired resistance of lung adenocarcinomas to gefitinib or erlotinib is associated with a second mutation in the EGFR kinase domain
W Pao et al.
PLOS MEDICINE (2005)
EGFR mutations in lung cancer:: Correlation with clinical response to gefitinib therapy
JG Paez et al.
SCIENCE (2004)
Green fluorescent protein tagging of extracellular signal-regulated kinase and p38 pathways reveals novel dynamics of pathway activation during primary and metastatic growth
JA Aguirre-Ghiso et al.
CANCER RESEARCH (2004)
Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib
TJ Lynch et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
A novel hypoxia-inducible factor-independent hypoxic response regulating mammalian target of rapamycin and its targets
AM Arsham et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Carbonic anhydrase IX expression, a novel surrogate marker of tumor hypoxia, is associated with a poor prognosis in non-small-cell lung cancer
DEB Swinson et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Gene 33/Mig-6, a transcriptionally inducible adapter protein that binds GTP-Cdc42 and activates SAPK/JNK - A potential marker transcript for chronic pathologic conditions, such as diabetic nephropathy. Possible role in the response to persistent stress
A Makkinje et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
